As a common transcription factor, E2F6 has been reported in many tumors, especially in glioma [81], liver cancer [82], gastric cancer [83], bladder cancer [84], etc. It is highly expressed in tumor tissues and is inversely proportional to patient prognosis. This evidence concerns the gene E2F6 and glioma.